cholestyramine resin has been researched along with Carcinogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, Y; Imajo, K; Iwaki, M; Kasai, Y; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Nogami, A; Ogawa, Y; Ozaki, A; Saito, S; Tanaka, K; Usuda, H; Wada, K; Yoneda, M | 1 |
1 other study(ies) available for cholestyramine resin and Carcinogenesis
| Article | Year |
|---|---|
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carcinogenesis; Cholestyramine Resin; Disease Models, Animal; Mice; Non-alcoholic Fatty Liver Disease | 2023 |